DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Erbitux (Cetuximab) - Death - Suspected Cause - Side Effect Reports

 
 



Index of reports > Death (139)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Erbitux (Cetuximab) death. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 139   Next >>

Possible Erbitux side effects in 76 year old male

Reported by a consumer/non-health professional from Japan on 2012-08-07

Patient: 76 year old male, weighing 57.0 kg (125.4 pounds)

Reactions: Lung Disorder, Skin Disorder

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Irinotecan HCL
    Indication: Colorectal Cancer Recurrent

Erbitux
    Dosage: 250mg/m2:unk 300mg/m2:jan12-25jan12
    Indication: Colorectal Cancer Recurrent
    Start date: 2011-01-01
    End date: 2012-01-25

Other drugs received by patient: Fluorouracil; Restamin; Maglax; Rabeprazole Sodium; Furosemide; Acecol; Pursennid; Claritin; Pravastatin; Leucovorin Calcium; Mucosta; Depas; Dexamethasone Sodium Phosphate



Possible Erbitux side effects in male

Reported by a physician from France on 2012-08-06

Patient: male

Reactions: Disease Progression, Epistaxis

Adverse event resulted in: death

Drug(s) suspected as cause:
Erbitux
    Start date: 2010-06-15
    End date: 2010-09-08

Avastin
    Indication: Colon Cancer
    Start date: 2009-07-23
    End date: 2010-06-02

Vectibix
    Start date: 2010-11-23
    End date: 2010-12-17

Other drugs received by patient: Fluorouracil; Leucovorin Calcium; Oxaliplatin; Irinotecan HCL; Fluorouracil; Leucovorin Calcium; Irinotecan Hydrochloride



Possible Erbitux side effects in 76 year old male

Reported by a consumer/non-health professional from Germany on 2012-07-30

Patient: 76 year old male, weighing 57.0 kg (125.4 pounds)

Reactions: Lung Disorder, Skin Disorder

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Irinotecan HCL
    Indication: Colorectal Cancer Recurrent

Erbitux
    Dosage: 250mg/m2:unk 300mg/m2:jan12-stopped
    Indication: Colorectal Cancer Recurrent
    Start date: 2011-01-01

Other drugs received by patient: Maglax; Claritin; Acecol; Dexamethasone Sodium Phosphate; Pursennid; Pravastatin; Leucovorin Calcium; Mucosta; Restamin; Furosemide; Depas; Rabeprazole Sodium; Fluorouracil



Possible Erbitux side effects in 81 year old male

Reported by a consumer/non-health professional from United States on 2012-07-24

Patient: 81 year old male, weighing 91.0 kg (200.2 pounds)

Reactions: Head Injury, Fall

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Erbitux



Possible Erbitux side effects in 64 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-24

Patient: 64 year old male, weighing 111.0 kg (244.2 pounds)

Reactions: Dermatitis Acneiform, Weight Decreased, Dyspnoea, Dysphonia, Recall Phenomenon, Pneumonia Staphylococcal, Myocardial Infarction

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Taxotere
    Dosage: total dose: 32 mg,last administered:30oct2006
    Indication: Head and Neck Cancer
    Start date: 2006-10-30
    End date: 2006-10-30

Erbitux
    Dosage: arm 1:400mg/m2,iv:120 min,day 1,other chemo/radiation that day/week.last adminstered:30oct06,540mg
    Indication: Head and Neck Cancer
    Start date: 2006-10-30
    End date: 2006-10-30



Possible Erbitux side effects in 71 year old male

Reported by a consumer/non-health professional from Germany on 2012-07-24

Patient: 71 year old male, weighing 72.0 kg (158.4 pounds)

Reactions: Dyspnoea, Sepsis, Pyrexia

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Erbitux

Other drugs received by patient: Leucovorin Calcium; Ondansetron; Fluorouracil; Oxaliplatin



Possible Erbitux side effects in 55 year old male

Reported by a consumer/non-health professional from United States on 2012-07-13

Patient: 55 year old male

Reactions: Death, Back Pain, Dysphagia, Dehydration, Cough

Adverse event resulted in: death

Drug(s) suspected as cause:
Erbitux
    Indication: Head and Neck Cancer

Erbitux
    Indication: Hepatic Neoplasm Malignant

Other drugs received by patient: Methadone HCL; Ibuprofen; Vicodin



Possible Erbitux side effects in 43 year old female

Reported by a consumer/non-health professional from United States on 2012-07-11

Patient: 43 year old female, weighing 33.0 kg (72.6 pounds)

Reactions: Pneumonia, Respiratory Failure, Neutropenia, Septic Shock, Thrombocytopenia

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Erbitux
    Dosage: 23sp11=1d(d1ofcycle1only),30sp11-ong 250mg/m2(297mg)(ondy 1,8+15 everycycle),dose 5oc11,3nv11,10nv11
    Indication: Head and Neck Cancer
    Start date: 2011-09-23

Cisplatin
    Dosage: day 1 every cycle,last dose on 23sep11
    Indication: Head and Neck Cancer
    Start date: 2011-09-23
    End date: 2011-09-23

Fluorouracil
    Dosage: on day 1 -4,last dose on 26sep11
    Indication: Head and Neck Cancer
    Start date: 2011-09-23
    End date: 2011-09-26



Possible Erbitux side effects in 45 year old male

Reported by a health professional (non-physician/pharmacist) from Germany on 2012-07-06

Patient: 45 year old male, weighing 75.0 kg (165.0 pounds)

Reactions: Diarrhoea, Ileus

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Erbitux

Other drugs received by patient: Antihistamine Drugs; Corticosteroid; Pantoprazole; Fluorouracil; Irinotecan HCL; Leucovorin Calcium; Oxaliplatin; Hydromorphone HCL; Acetaminophen



Possible Erbitux side effects in 46 year old male

Reported by a consumer/non-health professional from France on 2012-07-03

Patient: 46 year old male

Reactions: Death, Dyspnoea

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Morphine Sulfate
    Dosage: also received 30mg
    Administration route: Oral
    Indication: Cancer Pain
    Start date: 2012-01-01
    End date: 2012-05-05

Fluorouracil
    Dosage: no of course:2
    Start date: 2012-05-05

Cisplatin
    Dosage: no of course:2
    Start date: 2012-05-05

Erbitux
    Dosage: no of course:2
    Start date: 2012-05-05

Oramorph SR
    Dosage: 1 df = 40 to 60 mg,also received 260mg,20mg
    Administration route: Oral
    Indication: Cancer Pain

Methadone HCL
    Dosage: methadone ap-hp,also received 40mg
    Administration route: Oral
    Indication: Cancer Pain
    Start date: 2012-05-06



Possible Erbitux side effects in

Reported by a consumer/non-health professional from Germany on 2012-06-27

Patient:

Reactions: Neutropenia, Renal Failure Acute

Adverse event resulted in: death

Drug(s) suspected as cause:
Erbitux



Possible Erbitux side effects in 50 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-22

Patient: 50 year old female, weighing 46.7 kg (102.8 pounds)

Reactions: Death, Lymphopenia, Oropharyngeal Cancer Stage Unspecified, Progressive Multifocal Leukoencephalopathy

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Rituximab
    Indication: Rheumatoid Arthritis
    Start date: 2006-11-01
    End date: 2006-11-02

Prednisone TAB
    Administration route: Oral
    Start date: 2003-07-01

Rituximab
    Start date: 2004-12-01

Carboplatin
    Indication: Tonsil Cancer
    Start date: 2007-08-07
    End date: 2007-09-21

Methylprednisolone
    Start date: 2004-03-16
    End date: 2006-11-11

Prednisone TAB
    Dosage: dose unknown, days 2-14
    Administration route: Oral
    Indication: Rheumatoid Arthritis

Prednisone TAB
    Administration route: Oral
    Start date: 2003-07-01

Rituximab
    Start date: 2003-07-01

Erbitux
    Indication: Tonsil Cancer
    Start date: 2007-08-07

Methylprednisolone
    Indication: Premedication
    Start date: 2003-07-01

Remicade
    Indication: Product Used FOR Unknown Indication
    Start date: 2002-03-01

Methylprednisolone
    Start date: 2003-07-01

Prednisone TAB
    Dosage: dose unknown, days 2-14
    Administration route: Oral
    Indication: Premedication

Rituximab
    Start date: 2004-03-01

Methylprednisolone
    Indication: Rheumatoid Arthritis
    Start date: 2004-03-16
    End date: 2006-11-11

Other drugs received by patient: Nexium; Estrogen; Hydroxychloroquine Sulfate; Acyclovir; Doxycycline; Folic Acid; Ranitidine; Calcium W / Vitamin D; Lovenox; Lodine; Diflucan; Lotrisone; Levothyroxine; Vigamox; Oxycontin; Clindamycin; Decadron; Cymbalta; Methotrexate; Reglan; Darvocet; Invanz; Fluconazole; Provigil



Possible Erbitux side effects in 63 year old male

Reported by a consumer/non-health professional from United States on 2012-06-21

Patient: 63 year old male

Reactions: Pneumonia, Neoplasm Malignant

Adverse event resulted in: death

Drug(s) suspected as cause:
Erbitux
    Dosage: last dose on 13mar12
    Indication: Laryngeal Cancer
    Start date: 2012-02-01
    End date: 2012-03-13

Erbitux
    Dosage: last dose on 13mar12
    Indication: Oropharyngeal Cancer Stage Unspecified
    Start date: 2012-02-01
    End date: 2012-03-13

Erbitux
    Dosage: last dose on 13mar12
    Indication: Throat Cancer
    Start date: 2012-02-01
    End date: 2012-03-13



Possible Erbitux side effects in 75 year old male

Reported by a consumer/non-health professional from Germany on 2012-06-19

Patient: 75 year old male, weighing 57.0 kg (125.4 pounds)

Reactions: Lung Disorder

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Erbitux

Other drugs received by patient: Maglax; Pravastatin; Pursennid; Mucosta; Claritin; Acecol; Furosemide; Depas; Rabeprazole Sodium



Possible Erbitux side effects in 75 year old male

Reported by a health professional (non-physician/pharmacist) from Germany on 2012-06-19

Patient: 75 year old male, weighing 64.0 kg (140.8 pounds)

Reactions: Pneumonia, Cardiac Failure Congestive

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Erbitux
    Dosage: strength:5mg/ml recent inf(10th):15nov10
    Indication: Head and Neck Cancer
    Start date: 2010-09-06
    End date: 2010-11-15

Cisplatin
    Dosage: recent inf(4th):15nov10
    Indication: Head and Neck Cancer
    Start date: 2010-09-06
    End date: 2010-11-15

Fluorouracil
    Dosage: continuous inf from day 1 to day 4 of cycle recent inf(4th):15nov10
    Indication: Head and Neck Cancer
    Start date: 2010-09-06
    End date: 2010-11-19



Possible Erbitux side effects in 43 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-15

Patient: 43 year old female, weighing 33.0 kg (72.6 pounds)

Reactions: Pneumonia, Respiratory Failure, Neutropenia, Thrombocytopenia, Septic Shock

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Cisplatin
    Dosage: day 1 every cycle,last dose on 23sep11
    Indication: Head and Neck Cancer
    Start date: 2011-09-23

Erbitux
    Dosage: 23sp11=1d(d1ofcycle1only),30sp11-ong 250mg/m2(297mg)(ondy 1,8+15 everycycle),dose 5oc11,3nv11,10nv11
    Indication: Head and Neck Cancer
    Start date: 2011-09-23

Fluorouracil
    Dosage: on day 1 -4,last dose on 26sep11
    Indication: Head and Neck Cancer
    Start date: 2011-09-23



Possible Erbitux side effects in 64 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-10

Patient: 64 year old male, weighing 111.0 kg (244.2 pounds)

Reactions: Dermatitis Acneiform, Weight Decreased, Dyspnoea, Dysphonia, Radiation Injury, Pneumonia Staphylococcal, Myocardial Infarction

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Erbitux
    Dosage: arm 1:400mg/m2,iv:120 min,day 1,other chemo/radiation that day/week.last adminstered:30oct06,540mg
    Indication: Head and Neck Cancer
    Start date: 2006-10-30
    End date: 2006-10-30

Taxotere
    Dosage: total dose: 32 mg,last administered:30oct2006
    Indication: Head and Neck Cancer
    Start date: 2006-10-30
    End date: 2006-10-30



Possible Erbitux side effects in 43 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-07

Patient: 43 year old female, weighing 33.0 kg (72.6 pounds)

Reactions: Pneumonia, Respiratory Failure, Neutropenia, Thrombocytopenia, Septic Shock

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Cisplatin
    Dosage: day 1 every cycle,last dose on 23sep11
    Indication: Head and Neck Cancer
    Start date: 2011-09-23

Fluorouracil
    Dosage: on day 1 -4,last dose on 26sep11
    Indication: Head and Neck Cancer
    Start date: 2011-09-23

Erbitux
    Dosage: 23sp11=1d(d1ofcycle1only),30sp11-ong 250mg/m2(297mg)(ondy 1,8+15 everycycle),dose 5oc11,3nv11,10nv11
    Indication: Head and Neck Cancer
    Start date: 2011-09-23



Possible Erbitux side effects in 43 year old female

Reported by a consumer/non-health professional from United States on 2012-06-06

Patient: 43 year old female, weighing 33.0 kg (72.6 pounds)

Reactions: Pneumonia, Respiratory Failure, Neutropenia, Septic Shock, Thrombocytopenia

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Cisplatin
    Dosage: day 1 every cycle,last dose on 23sep11
    Indication: Head and Neck Cancer
    Start date: 2011-09-23

Erbitux
    Dosage: 23sep11=1d(d1ofcycle1only),30sep11-ong 250mg/m2(297mg)(on day 1,8+15 everycycle),last dose on5oct11
    Indication: Head and Neck Cancer
    Start date: 2011-09-23

Fluorouracil
    Dosage: on day 1 -4,last dose on 26sep11
    Indication: Head and Neck Cancer
    Start date: 2011-09-23



Possible Erbitux side effects in 76 year old male

Reported by a health professional (non-physician/pharmacist) from Germany on 2012-06-04

Patient: 76 year old male, weighing 71.0 kg (156.2 pounds)

Reactions: Hypotension, General Physical Health Deterioration, Hepatic Failure, Dizziness

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Erbitux

Other drugs received by patient: Capecitabine



Possible Erbitux side effects in 54 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-29

Patient: 54 year old male

Reactions: Death, Vomiting, Nausea

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Erbitux
    Indication: non-Small Cell Lung Cancer
    Start date: 2011-04-11

Carboplatin
    Indication: non-Small Cell Lung Cancer
    Start date: 2011-04-11

Lortab
    Indication: Product Used FOR Unknown Indication

Atripla
    Indication: Product Used FOR Unknown Indication

Taxol
    Indication: non-Small Cell Lung Cancer
    Start date: 2011-04-11

Fentanyl
    Indication: Product Used FOR Unknown Indication



Possible Erbitux side effects in 60 year old male

Reported by a pharmacist from United States on 2012-05-25

Patient: 60 year old male, weighing 111.0 kg (244.2 pounds)

Reactions: Agitation, Dyspnoea, Pruritus, Unresponsive To Stimuli, Cardiac Disorder, Flushing, Incoherent, Cyanosis, Ocular Hyperaemia, Pulse Absent

Adverse event resulted in: death

Drug(s) suspected as cause:
Erbitux
    Dosage: 800mg once iv
    Indication: Tonsil Cancer
    Start date: 2012-05-14
    End date: 2012-05-14

Erbitux



Possible Erbitux side effects in 54 year old male

Reported by a physician from United States on 2012-05-22

Patient: 54 year old male

Reactions: Death, Vomiting, Nausea, Cough

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Lortab

Fentanyl-100

Carboplatin
    Dosage: 545 mg total
    Indication: non-Small Cell Lung Cancer
    Start date: 2011-04-11
    End date: 2011-01-01

Taxol
    Dosage: 269 mg total
    Indication: non-Small Cell Lung Cancer
    Start date: 2011-04-11
    End date: 2011-01-01

Erbitux
    Dosage: 447.5 mg total
    Indication: non-Small Cell Lung Cancer
    Start date: 2011-04-11

Atripla



Possible Erbitux side effects in male

Reported by a physician from United States on 2012-05-17

Patient: male

Reactions: Death, Malaise

Adverse event resulted in: death

Drug(s) suspected as cause:
Taxol

Zometa
    Start date: 2011-04-01

Erbitux



Possible Erbitux side effects in 76 year old female

Reported by a health professional (non-physician/pharmacist) from France on 2012-05-15

Patient: 76 year old female, weighing 80.0 kg (176.0 pounds)

Reactions: Colon Cancer Metastatic, Intracranial Tumour Haemorrhage, Central Nervous System Lesion, General Physical Health Deterioration, Somnolence, Disease Progression, Diarrhoea, Brain Oedema, Neutropenia, Escherichia Sepsis

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Erbitux
    Dosage: unk
    Indication: Colon Cancer Metastatic
    Start date: 2009-04-07
    End date: 2009-05-05

Irinotecan HCL
    Dosage: unk
    Indication: Colon Cancer Metastatic
    Start date: 2008-09-10
    End date: 2009-05-05

Levoleucovorin Calcium
    Dosage: unk
    Start date: 2008-09-10
    End date: 2009-04-07

Avastin
    Dosage: 5 mg/kg
    Indication: Colon Cancer Metastatic
    Start date: 2008-09-12
    End date: 2009-03-11

Fluorouracil
    Dosage: unk
    Indication: Colon Cancer Metastatic
    Start date: 2008-09-10
    End date: 2009-05-05

Other drugs received by patient: Polaramine; Actos; Repaglinide; Zofran; Celiprolol; Solu-Medrol; Neulasta; Pravastatin; Coaprovel; Atropine



Possible Erbitux side effects in 57 year old male

Reported by a health professional (non-physician/pharmacist) from Australia on 2012-05-10

Patient: 57 year old male

Reactions: Intestinal Obstruction

Adverse event resulted in: death

Drug(s) suspected as cause:
Erbitux



Possible Erbitux side effects in 80 year old male

Reported by a consumer/non-health professional from Germany on 2012-05-09

Patient: 80 year old male, weighing 47.0 kg (103.4 pounds)

Reactions: Interstitial Lung Disease, Decreased Appetite

Adverse event resulted in: death

Drug(s) suspected as cause:
Erbitux

Other drugs received by patient: Miya-BM; Loxonin; Oxinorm; Amoban; Magmitt; Amlodipine; Lansoprazole; Butylscopolamine; Oxycontin; Aitorol



Possible Erbitux side effects in 54 year old male

Reported by a consumer/non-health professional from United States on 2012-05-08

Patient: 54 year old male, weighing 66.0 kg (145.2 pounds)

Reactions: Death, Vomiting, Nausea

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Atripla

Lortab

Erbitux
    Dosage: courses:18 last dose on 22aug2011
    Indication: non-Small Cell Lung Cancer
    Start date: 2011-04-11

Fentanyl

Carboplatin
    Dosage: last dose on 08aug2011 courses:18
    Indication: non-Small Cell Lung Cancer
    Start date: 2011-04-11

Taxol
    Dosage: courses:18 last dose on 08aug2011
    Indication: non-Small Cell Lung Cancer
    Start date: 2011-04-11



Possible Erbitux side effects in 56 year old female

Reported by a consumer/non-health professional from United States on 2012-05-07

Patient: 56 year old female, weighing 105.0 kg (231.0 pounds)

Reactions: Acute Myelomonocytic Leukaemia

Adverse event resulted in: death

Drug(s) suspected as cause:
Carboplatin
    Dosage: 1df=auc 5 on day 1 it last dose:25oct2010 2ns line trt:15nov-20dec10
    Indication: non-Small Cell Lung Cancer
    Start date: 2010-08-23
    End date: 2010-11-08

Gemzar
    Dosage: last dose:1nov2010 4cycles
    Indication: non-Small Cell Lung Cancer
    Start date: 2010-08-23
    End date: 2010-11-08

Erbitux
    Dosage: 250mg/m2 on day 1.day 8 + 15 from 30aug10 last dose:1nov2010(64dys) inf:9 4cycles
    Indication: non-Small Cell Lung Cancer
    Start date: 2010-08-23
    End date: 2010-11-08

Other drugs received by patient: Vicodin; Zofran; Decadron; Ativan; Docetaxel; Aloxi



Possible Erbitux side effects in 67 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-04

Patient: 67 year old male, weighing 70.0 kg (154.0 pounds)

Reactions: Cardiac Arrest, Pneumonitis

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Erbitux
    Dosage: 1st 400 mg/m2(17-jan), then 250 mg/m2 on 24-jan, 31-jan,07-feb,14-feb,21-feb and 28-feb-2006(wk 2-7)
    Indication: Head and Neck Cancer
    Start date: 2006-02-28
    End date: 2006-02-28

Cisplatin
    Dosage: 30 mg/m2 week 2 thru 7-on 24-jan, 31-jan,07-feb,14-feb,21-feb and 28-feb-2006(wk 2-7)- 30 mg/m2
    Indication: Head and Neck Cancer
    Start date: 2006-02-28
    End date: 2006-02-28

Other drugs received by patient: Vytorin; Accupril; Cardizem; Tylenol W / Codeine; Reglan; Colace; Ativan; Oxycodone HCL; Senokot



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2012